Hub overview
Sponsor Briefing
A single-sponsor deep dive: trial volume, Australian-site share, execution reliability, the Australian recruiting trend, therapeutic areas, and PBS-listed medicines, pulled together for one sponsor and ready to export.
Loading...
What do these terms mean?
- ABS
- The Australian Bureau of Statistics, the source of the population and SEIFA figures.
- SEIFA
- Socio-Economic Indexes for Areas: the ABS ranking of areas by relative socio-economic advantage and disadvantage.
- IRSAD
- Index of Relative Socio-economic Advantage and Disadvantage, one of the SEIFA indexes. Shown in deciles from 1 (most disadvantaged) to 10 (most advantaged).
- CC BY
- A Creative Commons Attribution licence: the data is free to reuse, including commercially, as long as the source is attributed.
- YoY
- Year on year: a change measured against the same point twelve months earlier.
- AU
- Australia or Australian, for example a trial with at least one Australian site.
- P1+2+3
- Phase 1 plus Phase 2 plus Phase 3 registered trials combined, a measure of overall registered research activity for a condition.
- Condition acronyms
- ADHD: attention deficit hyperactivity disorder. COPD: chronic obstructive pulmonary disease. OCD: obsessive compulsive disorder. PTSD: post traumatic stress disorder.
Aggregated public data, not medical or investment advice. Trial data from ClinicalTrials.gov; PBS medicine listings from the Pharmaceutical Benefits Scheme (Commonwealth of Australia), shown verbatim and unmodified, and matched to a sponsor by manufacturer name (some listings may not be shown). Compiled by Voxsanity (voxsanity.com.au). Please attribute Voxsanity when reproducing this analysis elsewhere.